Reimbursement routes and past practices for advanced therapy medicinal products in the Netherlands. [PDF]
Gort J +6 more
europepmc +1 more source
Development of an investigational medicinal stem cell gene therapy product to attempt curing human immunodeficiency virus infection. [PDF]
Weigand L +11 more
europepmc +1 more source
Regulatory approach to manipulated organs in Europe: preserving human organs as non-commercial goods. [PDF]
Cuende N, Izeta A, Domínguez-Gil B.
europepmc +1 more source
Do conditional marketing authorisations actually accelerate patient access? Time-to-access of conditional vs. standard marketing authorisations in Italy, Spain, and Germany. [PDF]
Ardito V +6 more
europepmc +1 more source
Vulnerability, protection and fairness: ethical and regulatory limits in small-N gene therapy trials. [PDF]
Reckelbus M +3 more
europepmc +1 more source
Bone Marrow Mononuclear Cells and Plasma Gel as Combination Treatment for Hard-to-Heal Wounds. [PDF]
Perez-Lopez S +8 more
europepmc +1 more source
A decade of clinical trials in Italy (2016-2025): trends, regulatory transformation and biotechnological evolution. [PDF]
De Paola E +3 more
europepmc +1 more source
Co<sub>2</sub>P@CoPi@NC with engineered heterointerfaces and carbon networks for hydrazine-assisted water splitting. [PDF]
Zhao H +4 more
europepmc +1 more source
The overlooked role of manganese in biodegradation studies of higher aminopolyphosphonates. [PDF]
Kourtaki K, Martin PR, Haderlein SB.
europepmc +1 more source
The Italian Assessment System for Innovative Medicines: An 8-Year Retrospective Analysis of Outcomes, Criteria, Timelines and Funding Dynamics. [PDF]
Martellone L +7 more
europepmc +1 more source

